pravastatin has been researched along with Graft vs Host Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, CS; Kim, TJ; Lim, JY; Min, CK; Yoon, HK | 1 |
Chiba, S; Goyama, S; Hamaki, T; Hirai, H; Hori, A; Imataki, O; Kami, M; Kanda, Y; Kishi, Y; Kojima, R; Komeno, Y; Makimoto, A; Mitani, K; Ogawa, S; Onishi, Y; Sakiyama, M; Takaue, Y; Tanosaki, R | 1 |
1 trial(s) available for pravastatin and Graft vs Host Disease
Article | Year |
---|---|
A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host disease.
Topics: Chronic Disease; Graft vs Host Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Th1 Cells; Th2 Cells | 2005 |
1 other study(ies) available for pravastatin and Graft vs Host Disease
Article | Year |
---|---|
Effects of pravastatin on murine chronic graft-versus-host disease.
Topics: Animals; Chemokines; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Graft vs Host Disease; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Minor Histocompatibility Antigens; Pravastatin; Skin Transplantation; Transplantation, Isogeneic | 2010 |